National AIDS Treatment Advocacy Project, NYU/Bellevue Center for AIDS Research CFAR) and The AIDS Clinical Trials Unit present:

Community Lecture Series
on Emergine Issues on HIV/AIDS Therapies
Fifth in a Series of NATAP Seminars

HIV Current Issues in Treatment

Report from the International AIDS Conference in Geneva

Saturday, July 18, 1998
NYU Medical Center, Farkas Auditorium
East 31st Street and 1st Avenue
10 am - 3 pm

Speakers

Trip Gulick, MD
Cornell-New York Hospital, Chelsea Center

Nick Hellman, MD
ViroLogic, Inc

(Phenotypic Test Maker)

James Jones, MD
Manhattan Medical Center

Brendan Larder, PhD and Rudi Pauwells, PhD
Virco-Belgium
(Phenotypic Test Maker)

Doug Mayers, MD
Henry Ford Hospital in Detroit

Jean-Louis Salinas, MD
Boriken Family Health Center

Fred Valentine
NYU/Bellevue Medical Center

Moderator: Jules Levin, Executive Director, NATAP

Topics
 
Review of the latest treatment information from Geneva

Phenotypic and genotypic resistance testing

Data on new drugs-- 141W94, Efavirenz, Adefovir, 1592U89

A Special Report from the June International Resistance Workshop in Milan

HIV Pathogenesis, viral dynamics, viral life cycle, immune restoration, and viral reservoirs

The latest data on lowering viral load to below 50 copies

Adherence: How it relates to resistance and methods to improve it

Preventing treatment failure

Improving the patient/doctor relationship

Question and Answer after each speaker

Co-Sponsors: AIDS Services, Black Leadership Council, Body Positive, Bronx AIDS Task Force, Brooklyn AIDS Task Force, Caribbean Women's Health Organization, Community Prescription Service, Community Research Initiative on AIDS, Exponents/Arrive, Gay Men of African Descent, Greenwick House, Haitian Women's Program, Iris House, Latino Commission on AIDS, Life Force, Minority Task Force on AIDS, Mt. Sinai AIDS Center, Music Against Drugs, NYU/Bellevue AIDS, ACTU, PWA Coalition-NY, St. Vincent's AIDS Clinic, Stadtlanders Pharmacy, Staten Island AIDS Task Force, The Village Apothecary, Woodhull Medical Center AIDS Center Program.